Skip to main content
Log in

Distinct subgroups of paroxysmal nocturnal hemoglobinuria (PNH) with cytopenia: results from South Korean National PNH Registry

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

We retrospectively assessed the clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria (PNH) according to severity of cytopenia. A total of 282 patients with hematological parameters assessed at the time of diagnosis of PNH were included. There were 24 patients with PNH/severe aplastic anemia (SAA) (at least two of the three criteria; hemoglobin ≤8 g/dL; absolute neutrophil count (ANC) <0.5 × 109/L; platelet count <20 × 109/L), 96 patients with PNH/aplastic anemia (AA) (at least two of the three criteria; hemoglobin ≤10 g/dL; ANC 0.5–1.5 × 109/L; platelet count 20–100 × 109/L), and 162 classic PNH patients. Compared with the classic PNH subgroup, the PNH/SAA subgroup had a significantly lower median granulocyte PNH clone size (26.7 vs. 51.0 %, P = 0.021) and lower incidence of lactate dehydrogenase ≥1.5 times the upper limit of normal (52.9 vs. 80.0 %, P = 0.049). The incidence of thromboembolism was similar in both subgroups. Overall survival was significantly lower in the PNH/SAA subgroup than in the classic PNH subgroup (P = 0.033). Our findings suggest that identification of patients with PNH/SAA at the time of diagnosis is important because of different clinical manifestations and poorer outcome compared with patients with classic PNH (clinicaltrials.gov identifier: #NCT01224483).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV (1995) Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 333(19):1253–1258. doi:10.1056/NEJM199511093331904

    Article  PubMed  CAS  Google Scholar 

  2. Parker CJ (2012) Paroxysmal nocturnal hemoglobinuria. Curr Opin Hematol 19(3):141–148. doi:10.1097/MOH.0b013e328351c348

    Article  PubMed  CAS  Google Scholar 

  3. Socie G, Mary JY, de Gramont A, Rio B, Leporrier M, Rose C, Heudier P, Rochant H, Cahn JY, Gluckman E (1996) Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet 348(9027):573–577

    Article  PubMed  CAS  Google Scholar 

  4. Nishimura J, Kanakura Y, Ware RE, Shichishima T, Nakakuma H, Ninomiya H, Decastro CM, Hall S, Kanamaru A, Sullivan KM, Mizoguchi H, Omine M, Kinoshita T, Rosse WF (2004) Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan. Medicine (Baltimore) 83(3):193–207

    Article  Google Scholar 

  5. Lee JW, Jang JH, Kim JS, Yoon SS, Lee JH, Kim YK, Jo DY, Chung J, Sohn SK (2013) Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry. Int J Hematol 97(6):749–757. doi:10.1007/s12185-013-1346-4

    Article  PubMed  Google Scholar 

  6. Brodsky RA (2008) Paroxysmal nocturnal hemoglobinuria: stem cells and clonality. Hematology Am Soc Hematol Educ Program:111–115. doi:10.1182/asheducation-2008.1.111

  7. Pu JJ, Brodsky RA (2011) Paroxysmal nocturnal hemoglobinuria from bench to bedside. Clin Transl Sci 4(3):219–224. doi:10.1111/j.1752-8062.2011.00262.x

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  8. de Latour RP, Mary JY, Salanoubat C, Terriou L, Etienne G, Mohty M, Roth S, de Guibert S, Maury S, Cahn JY, Socie G, French Society of H, French Association of Young H (2008) Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood 112(8):3099–3106. doi:10.1182/blood-2008-01-133918

    Article  Google Scholar 

  9. Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, Hillmen P, Luzzatto L, Young N, Kinoshita T, Rosse W, Socie G, International PNHIG (2005) Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 106(12):3699–3709. doi:10.1182/blood-2005-04-1717

    Article  Google Scholar 

  10. Pu JJ, Mukhina G, Wang H, Savage WJ, Brodsky RA (2011) Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia. Eur J Haematol 87(1):37–45. doi:10.1111/j.1600-0609.2011.01615.x

    Article  PubMed  PubMed Central  Google Scholar 

  11. Raza A, Ravandi F, Rastogi A, Bubis J, Lim SH, Weitz I, Castro-Malaspina H, Galili N, Jawde RA, Illingworth A (2014) A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure. Cytometry B Clin Cytom 86(3):175–182. doi:10.1002/cyto.b.21139

    Article  PubMed  Google Scholar 

  12. Schrezenmeier H, Muus P, Socie G, Szer J, Urbano-Ispizua A, Maciejewski JP, Brodsky RA, Bessler M, Kanakura Y, Rosse W, Khursigara G, Bedrosian C, Hillmen P (2014) Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica 99(5):922–929. doi:10.3324/haematol.2013.093161

    Article  PubMed  PubMed Central  Google Scholar 

  13. Hillmen P, Young NS, Schubert J, Brodsky RA, Socie G, Muus P, Roth A, Szer J, Elebute MO, Nakamura R, Browne P, Risitano AM, Hill A, Schrezenmeier H, Fu CL, Maciejewski J, Rollins SA, Mojcik CF, Rother RP, Luzzatto L (2006) The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 355(12):1233–1243. doi:10.1056/NEJMoa061648

    Article  PubMed  CAS  Google Scholar 

  14. Kim JS, Lee JW, Kim BK, Lee JH, Chung J (2010) The use of the complement inhibitor eculizumab (Soliris(R)) for treating Korean patients with paroxysmal nocturnal hemoglobinuria. Korean J Hematol 45(4):269–274. doi:10.5045/kjh.2010.45.4.269

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  15. Peffault de Latour R, Schrezenmeier H, Bacigalupo A, Blaise D, de Souza CA, Vigouroux S, Willemze R, Terriou L, Tichelli A, Mohty M, de Guibert S, Marsh JC, Passweg J, Yves Mary J, Socie G (2012) Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria. Haematologica 97(11):1666–1673. doi:10.3324/haematol.2012.062828

    Article  PubMed  Google Scholar 

  16. Pantin J, Tian X, Geller N, Ramos C, Cook L, Cho E, Scheinberg P, Vasu S, Khuu H, Stroncek D, Barrett J, Young NS, Donohue T, Childs RW (2014) Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria. Biol Blood Marrow Transplant 20(9):1435–1439. doi:10.1016/j.bbmt.2014.05.012

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  17. Brodsky RA, Young NS, Antonioli E, Risitano AM, Schrezenmeier H, Schubert J, Gaya A, Coyle L, de Castro C, Fu CL, Maciejewski JP, Bessler M, Kroon HA, Rother RP, Hillmen P (2008) Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood 111(4):1840–1847. doi:10.1182/blood-2007-06-094136

    Article  PubMed  CAS  Google Scholar 

  18. Marsh JC, Ball SE, Cavenagh J, Darbyshire P, Dokal I, Gordon-Smith EC, Keidan J, Laurie A, Martin A, Mercieca J, Killick SB, Stewart R, Yin JA, British Committee for Standards in H (2009) Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol 147(1):43–70. doi:10.1111/j.1365-2141.2009.07842.x

    Article  PubMed  CAS  Google Scholar 

  19. Brodsky RA (2009) How I treat paroxysmal nocturnal hemoglobinuria. Blood 113(26):6522–6527. doi:10.1182/blood-2009-03-195966

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  20. Brodsky RA (2010) Stem cell transplantation for paroxysmal nocturnal hemoglobinuria. Haematologica 95(6):855–856. doi:10.3324/haematol.2010.023176

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kelly RJ, Hill A, Arnold LM, Brooksbank GL, Richards SJ, Cullen M, Mitchell LD, Cohen DR, Gregory WM, Hillmen P (2011) Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood 117(25):6786–6792. doi:10.1182/blood-2011-02-333997

    Article  PubMed  CAS  Google Scholar 

  22. Lee JL, Lee JH, Lee JH, Choi SJ, Kim S, Seol M, Lee YS, Chi HS, Park CJ, Kim WK, Lee JS, Lee KH (2003) Allogeneic hematopoietic cell transplantation for paroxysmal nocturnal hemoglobinuria. Eur J Haematol 71(2):114–118

    Article  PubMed  Google Scholar 

  23. Scheinberg P, Young NS (2012) How I treat acquired aplastic anemia. Blood 120(6):1185–1196. doi:10.1182/blood-2011-12-274019

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  24. Kulagin A, Lisukov I, Ivanova M, Golubovskaya I, Kruchkova I, Bondarenko S, Vavilov V, Stancheva N, Babenko E, Sipol A, Pronkina N, Kozlov V, Afanasyev B (2014) Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study. Br J Haematol 164(4):546–554. doi:10.1111/bjh.12661

    Article  PubMed  CAS  Google Scholar 

  25. Sugimori C, Chuhjo T, Feng X, Yamazaki H, Takami A, Teramura M, Mizoguchi H, Omine M, Nakao S (2006) Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood 107(4):1308–1314. doi:10.1182/blood-2005-06-2485

    Article  PubMed  CAS  Google Scholar 

  26. Hall C, Richards S, Hillmen P (2003) Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood 102(10):3587–3591. doi:10.1182/blood-2003-01-0009

    Article  PubMed  CAS  Google Scholar 

  27. Moyo VM, Mukhina GL, Garrett ES, Brodsky RA (2004) Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays. Br J Haematol 126(1):133–138. doi:10.1111/j.1365-2141.2004.04992.x

    Article  PubMed  CAS  Google Scholar 

  28. Hill A, Kelly RJ, Hillmen P (2013) Thrombosis in paroxysmal nocturnal hemoglobinuria. Blood 121(25):4985–4996. doi:10.1182/blood-2012-09-311381, quiz 5105

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was presented in the form of a poster presentation at the 52nd annual meeting of the American Society of Hematology, Orlando, FL, December 4–7, 2010. This work was supported by the Korean Society of Hematology.

Conflict of interest

All authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jong Wook Lee.

Additional information

Jin Seok Kim and Jun Ho Jang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, J.S., Jang, J.H., Yoon, SS. et al. Distinct subgroups of paroxysmal nocturnal hemoglobinuria (PNH) with cytopenia: results from South Korean National PNH Registry. Ann Hematol 95, 125–133 (2016). https://doi.org/10.1007/s00277-015-2511-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-015-2511-z

Keywords

Navigation